Immix... recnac latceroloc ni 011-XMI r-Secret

Current Location: Home >Dashboard / Analytics >Immix... recnac latceroloc ni 011-XMI r Details

Immix... recnac latceroloc ni 011-XMI r

Date: 2025-06-13 12:27:06 Source: Secret Author: Markets Views: 201

Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.

(Editor-in-Chief: News)

[1]

[2]

[3]

Previous: Biden... ymonoce ydaets dna suriv mets
Next: BTC... 4202 ,03 naJ no ralloD ni ecir